Cov lus qhia tshwj xeeb ntawm MedroxyProgesterone 17-acetate 丨 CAS CAS 71-58-9
|
Teem nqi |
USP42 |
|
Kev tshwm sim |
Dawb rau off-dawb, tsw ntxhiab, hmoov |
|
Lam xav |
97.0%-103.0% |
|
Daim qhia npe |
IR thiab UV conforms |
|
So |
Ywj siab rau hauv chloroform; soluble hauv acetone thiab hauv Dioxane; sparingly soluble hauv dej cawv thiab hauv methanol; me ntsis soluble hauv ether; insoluble hauv dej. |
|
TSHWJ XEEB REGICCER |
{{0 {}}℃~ +51 degree |
|
Ib tug neeg impurity |
1.0% Max. |
|
Tag nrho cov impurities |
1.5% Max. |
|
Melting taw tes |
Txog 205 degree |
|
Poob rau ziab |
1.0% Max. |
|
Muaj feem cuam tshuam a |
0.50% Max. |
|
Residual cov kuab tshuaj |
Methanol: 3000ppm Max. |
|
Micron |
100% dhau 20μm |
Tshuaj Lom Zem
Medroxypropesterone 17-acetate 丨 CAS CAS CAS 71-58-9 (Mpa) yog aSynthetic Progestin, ib tug derivative ntawm lub ntuj hormoneprogesteroneCov. Nws muaj cov potency thiab bioavailability vim nws acetylation ntawm 17-alpha txoj hauj lwm. MPa yog ib qho ntawm cov feem ntau siv progestins nyob rau hauv cov tshuaj.
Cov ntawv thov ntawm Medroxypropesterone acetate
1. Cov tshuaj tiv thaiv cov tshuaj tiv thaiv
MPa yog tus yuam sij muaj nyob rau hauv:
Cov tshuaj tiv thaiv tsis muaj kuabxws liDepo-Provera, uas muab lub sijhawm ntev (3-hli) kev tswj tsis pub muaj menyuam los ntawm kev txhaj tshuaj infamuscular lossis subcutaneous.
Qhov ntawm qhov ncauj tiv thaiv, feem ntau hauv kev sib xyaw nrog Etrewogens rau kev voj voog kev cai.
Nws txoj haujlwm hauv lub plab vim yog:
Inhibition ntawm ovulationLos ntawm suppressing Luteinizing hormone (lh) thiab follicle-stimulating hormone (FSH).
Thickening ntawm ncauj tsev menyuam hnoos qeev, ua cov phev nkag mus rau qhov nyuaj dua.
Thinning ntawm endometrium, txo qhov ntxim nyiam ntawm kev cog hniav.
2. Cov tshuaj hormone hloov kho (HRT)
Siv nyob rau hauvCov poj niam postmenopausalrauTiv thaiv qhov endometriumLos ntawm hyperplastic cuam tshuam ntawm estrogen thaum HRT.
Ua ke nrogEstradiolnyob rau hauv ntau hrt qauv los txo qhov kev pheej hmoo ntawmendometrial cancer.
3. Kev kho mob ntawm kev coj khaub ncaws
MedroxyProgesterone 17-acetate 丨 CAS CAS 71-58-9 yog siv nyob rau hauv:
Ensfunctional uterine los ntshav
Amenorrhea (tsis muaj kev coj khaub ncaws)
Menorrhagagia (Hnyav Cov Khaub Ncaws Ntshav)
Los ntawm kev maj mam progesterone, MPa pab tswj lub cev ntas thiab txhawb kev tawm tsam ib txwm los ntshav.
4. Kev tswj ntawm endometrisosis thiab fibroids
MPa pab rau kev tsim txom txoj kev loj hlob ntawmCov ntaub so ntswg kawgthiabuterine fibroidslos ntawm kev txo cov tshuaj estrogen stimulation los ntawm cov tswv yim tsis zoo.
5. Cancer Kho
Hauv qee cov tshuaj hormones hormones-rhiab heev, Mpa yog siv rau nws cov kev cuam tshuam tshuaj tiv thaiv estrogenic:
Endometrial carcinoma
Lub Cim Ntawm Lub Carcinom Calberoma
Tus mob cancer mis(Hauv kev xaiv cov xwm txheej, tshwj xeeb hauv cov poj niam postmenopausal uas tsis yog cov neeg sib tw rau txoj kev kho mob)
6. Appetite Stimulation hauv Cacexia
Hauv cov neeg mob nrog mob qog noj ntshav, cov mob AIDS, lossis mob hnyav:
MPA qee zaum tau hais txogSau npe tawmrauUa kom dim kom nce ntxivthiabtxhawb qhov hnyav nce.
Nws ua rauglucocorticoid receptorsthiab kev pab cuam nruab nrab cuam tshuam rau kev tshaib plab thiab metabolism.
7. Kev nce toj ntawm Gonadotropin tso tawm
Mpa yog siv rauTshuaj Dab Neeg CastrationlossisKev Lag Luam Txiaj NtsigHauv:
Kev Ua Phem Ua Phem(Hauv qee lub tebchaws, raws li ib feem ntawm cov haujlwm raug cai lossis tshuaj kho)
Nkauj dawb nraug
Gender-lees Cov Hormone Kho(ua ib feem ntawm androgen supression regimens)
Cov txiaj ntsig ntawm Medroxypropesterone acetate
1. Kev ua yeeb yam ntev thiab yooj yim
Cov ntawv uas muajMus txog 12 lub lis piam los ntawm kev tiv thaivnrog ib koob.
Pab tau rau cov tib neeg uas nyiam siv cov tshuaj txhua hnub lossis siv cov txheej txheem thaiv.
2. High efficacy
Thaum siv tau zoo, MPA muabTshaj 99% ua tau zoohauv kev tiv thaiv kev xeeb tub.
Txhim khu kev qha, nrog cov kev nkag siab zoo kom nkag siab zoo nkauj thiab kev nyab xeeb profile.
3. Versatility
MPa pab ntau txoj haujlwm:Kev tivthaiv, tshuaj tiv thaiv kab mob Hormones, kho mob cancer, thiab ntau dua.
Muaj nyob rau hauv qhov ncauj, txhaj tshuaj, thiab qee zaus cog lus.
4. Txo cov tshuaj estrogen nthuav tawm
Yuav siv tauYog tsis muaj estrogenNyob rau hauv cov poj niam nrog contraindications (piv txwv li, keeb kwm ntawm thrombosis lossis mis cancer muaj zog).
Pabtiv thaiv kom tsis txhob mob siabThaum lub sij hawm tsis sib haum tshuaj estrogen kho.
5. Cov ntaub ntawv muaj ntaub ntawv cia
Cov chaw kuaj mob dav ntau nrog ntau lab tus neeg mob thoob ntiaj teb.
Pom zoo los ntawm cov chaw tswj hwm thaj chaw, suav nrog covFDAthiabWHORau kev siv hauv Tsev Neeg Kev Npaj.
6. Nqi siv tau zoo
Generic formulations yog dav muaj.
Pubpheej yig thiab siv tauKev tswj hwm kev mob siab hormonal hauv kev noj qab haus huv siab thiab tau txais nyiaj tsawg.
7. Tej zaum tsis muaj kev tiv thaiv kev noj qab haus huv pab
Tej zaum yuav txo qhov kev pheej hmoo ntawm:
Endometrial cancer
Cov hlwv ntawm zes qe menyuam
Pelvic Inflamatory (PID)
Kuj txuam nrogTxo kev coj khaub ncawsthiabLub sijhawm sib duaSijhawm dhau sijhawm.
Tag
MedroxyProgesterone 17-acetate 丨 CAS CAS 71-58-9 yog muaj zog thiab muaj ntau yam hluavtaws muaj zog nrog cov ntawv thov kev kho mob uas muaj ntau yamKev Tiv Thaiv Ntev NtevrauCov Tshuaj Kho Mob Hloov Kho, kev coj khaub ncaws, thiaboncologyCov. Nws cov kev ua tau ntev ntev, pov thawj kev ua tau zoo, thiab dav kho cov kev siv nws ua rau muaj cov kev sib txuas lus tseem ceeb thiab cov tshuaj hormonal. Raws li kev kho mob xav tau zuj zus, MPa tseem ua haujlwm tseem ceeb hauv kev ua kom muaj txiaj ntsigKho dua tshiab, Cov tshuaj hormonal tshuav nyiaj, thiabPab Txhawbnyob rau hauv cov mob ua nyuaj.
Cim npe nrov: MedroxyProgesterone 17-acetate 丨 CAS 71-58-9, Tuam Tshoj Medroxypropesterone 17 -98-9 Cov Chaw Tsim Tshuaj, Chaw Tsim Tshuaj, Hoobkas

